Introduction 64
The last decades have seen substantial declines in malaria transmission in sub-Saharan 65
Africa that are largely attributable to increased access to effective control measures, 66
including insecticide-treated bednets, indoor residual spraying of insecticide and 67 artemisinin-based combination therapy(1,2). In settings where transmission has been low, 68 increased access to effective control interventions opens the possibility for malaria 69 elimination. In highly endemic settings, however, there are concerns around the potential 70 impact of failing to sustain interventions that reduce but do not stop transmission. Short-71 term decreases in malaria incidence due to reductions in transmission could be offset over 72 time by reductions in population immunity to malaria resulting from lower exposure to 73 parasites (3-5). 74 75 Gradual acquisition of immunity against symptomatic malaria is a key driver of the 76 epidemiology of malaria in endemic settings, where the incidence of disease typically 77 peaks in early childhood and then declines, while the prevalence of detectable 78 asymptomatic parasitemia increases throughout childhood before declining in adulthood 79 (6-12). While these epidemiologic patterns have been described across the transmission 80 spectrum, there are still many fundamental gaps in our understanding of the factors 81 driving the development of immunity, and of the independent roles of age and repeated 82 infection. One reason it has been challenging to study immunity to malaria is that there 83 are currently no reliable and quantifiable immune correlates of protection that can be 84 measured in epidemiological studies. In addition, there are few available datasets that 85 include both detailed clinical data and independent metrics of exposure at the individual 86 level. 87 88 Here, we use data from three parallel cohort studies conducted across the spectrum of 89 malaria transmission in Uganda to model and quantify the development of immunity 90 against symptomatic malaria as a function of transmission intensity and age. A key 91 strength of these studies is that they involved detailed clinical and entomological 92 surveillance of all study households. We focus on two specific types of immunity: anti-93 parasite immunity (i.e; the ability to control parasite densities upon infection) and anti-94 disease immunity (i.e; the ability to tolerate higher parasite infections without developing 95 objective fever), as they have been described as independent components of clinical 96 immunity (13). 97 98
Results

99
The three cohorts enrolled a total of 1021 children aged 6 months to 10 years from 331 100 randomly chosen households across the three study sites. This analysis was limited to 101 data from 773 children who experienced at least one patent P. falciparum infection 102 between August 2011 and November 2014. Figure 1 ). These incidences were consistent with results from monthly 109 entomological surveys conducted in all cohort households, with significantly higher 110 annual entomological inoculation rates (aEIR) recorded in Nagongera (median 51 111 infectious bites per year, range 10-582) as compared to Kihihi (median 8 infectious bites 112 per year, range 4-47) and Walukuba (median 2 infectious bites per year, range 1-8). 113
Interestingly, prevalence of asymptomatic parasitemia did not follow this same 114 relationship; the prevalence of asymptomatic parasitemia was highest in Nagongera, and 115 prevalences in the lower transmission sites were similar. 116 117 aEIR as a metric of individual exposure 118
To assess whether entomological metrics were a good indicator of individual exposure to 119 P. falciparum, we correlated the measured annual EIRs (aEIR) for each household 120 Individual hazards were estimated by fitting time-to-event models to the incidence data 122 from each site. We found a significant correlation between these two independent metrics 123 of exposure across sites (R 2 = 0.38, p<0.001). While aEIR explained less of the variance 124 between individuals within each site, the correlation was still significant for both 125 Nagongera (R 2 = 0.03, p=0.005) and Kanungu (R 2 = 0.12, p<0.001). 126 127
Anti-parasite immunity 128
Parasite densities developed upon infection decreased with increasing age in all settings 129 and for both symptomatic (passive detection) and asymptomatic (detected during routine 130 visits) infections. Despite the large variability in parasite densities recorded within and 131 between individuals, this trend is evident in the raw data ( Figure 3a) . A trend towards 132 lower parasite densities was also observed among individuals living in settings with 133 higher aEIRs (Nagongera), as compared to settings with lower aEIR (Kihihi and 134 Walukuba). 135
136
We considered multiple candidate models to describe the association between parasite 137 density, age and aEIR (supplementary material). Models allowing smooth (non-linear) 138 relationships with aEIR best fit the data. Models allowing for two-way interactions 139 between age and aEIR also outperformed models that didn't include interactions. 140
141
In moderate and high transmission settings (households with aEIR >5), increasing age 142 and increasing exposure were independently associated with decreases in the parasite 143 densities. On average, parasite densities decreased by a factor of 0.76 (95%CI 0.74-0.77) 144 for each additional year of age and by a factor of 0.73 (95%CI 0.70-0.76) for each two-145 fold increase in the aEIR. The relationship was less evident for the lower transmission 146 households (aEIR<5). In these settings, there continued to be a decreasing association 147 with age, but the expected parasite densities at any given age were equal or lower to those 148 observed in the higher exposure (aEIR>10) settings. 149 150 Figures 4a and 5a present the predicted parasite densities, as a function of age and aEIR, 151 according to the best fitting model. While an individual aged 1 year exposed to an aEIR 152 of 10 is expected to develop a parasite density of 14610 parasites/µL (95%CI 5924-153 36031 parasites/µL) upon infection, the expected parasite density goes down to 3237 154 parasites/µL (95%CI 1381-7586 parasites/µL) by age 10 years. In contrast, the expected 155 parasite density in an individual living in a setting with aEIR of 150 will be similar 13071 156 parasites/µL (95%CI 5256-32503 parasites/µL) at age 1 year, but significantly lower by 157 age 10 years (999 parasites/µL (95%CI 398-2508 parasites/µL )). 158
159
To test whether the observed associations with age could be explained by the cumulative 160 exposure over a life time, we also fit models where, instead of adjusting for the aEIR, we 161 adjusted for the cumulative number of infectious bites (i.e. the product of age and aEIR). 162
Results from these models are consistent with a smaller, yet independent effect of age on 163 the development of anti-parasite immunity; for any given level of cumulative exposure, 164
each additional year of life was associated with decreases in parasite densities by a factor 165 of 0.82 (95%CI 0.81-0.85). 166 167
Anti-disease immunity 168
We define anti-disease immunity as the ability to tolerate a given parasite density without 169 developing objective fever. Thus, we were interested in modeling temperatures recorded 170 at specific parasite densities, as a function of age and aEIR. Similar to the models 171 characterizing anti-parasite immunity, models including smooth effects and interactions 172 outperformed simpler models. 173
174
As expected, we found a strong association between parasite densities and objective 175 temperature ( Figure S1 ). Increases in parasite densities above 1000 parasites/µL were 176 associated with higher expected temperatures across ages and transmission settings. In 177 addition, we found a negative association between objective temperature at a given 178 parasite density and age (Figures 3b, 4b and 6). In moderate and high transmission 179 settings (aEIR>5), the objective temperature at a given parasite density decreased on 180 average by 0.08 o C (95%CI 0.07-0. experienced the infection at age 10 years ( Figure 6 ). This association was similar and 185 remained significant even when adjusting for cumulative exposure and for the differences 186 in incidence of non-malarial fever across age-groups ( Figure S3 ). 187 188 Similar to the anti-parasite immunity results described above, the observed association 189 between exposure level and anti-disease immunity was less evident than the association 190 with age. For moderate and high transmission settings (aEIR 5 to 300) there was a clear 191 negative association between objective temperature at a given parasite density and aEIR. 192
The objective temperature decreased by 0.07 o C (95%CI 0.05-0.10 o C) for each two-fold 193 increase in aEIR. However, the relationship did not follow this trend for lower 194 transmission settings. Children living in the lowest transmission settings (aEIR 1 to 5) 195 appeared to tolerate higher parasite densities than children living in moderate 196 transmission settings (aEIR 5 to 10). 197
198
As an alternative way to characterize anti-disease immunity, we used our best fitting 199 model to predict the fever threshold, defined as the minimum parasite density associated 200 with objective fever (temperature> 38 o C), across levels of age and aEIR (figure 5b). 201
Results from this analysis show that, for settings with moderate and high transmission 202
(aEIR>5), the fever threshold increases both with age and increasing exposure. Thus, 203 while a 1 year old child living in a setting with aEIR of 10 presenting with a parasite 204 density as low as 3747 parasites/µL (95%CI 777-11129 parasites/µL) will be expected to 205 be febrile, children older than 6 years of age exposed to very high transmission (aEIR 206 150) might be afebrile even with parasite densities higher than 60000 parasites/µL. Our results indicate independent effects of age on the acquisition of both anti-parasite and 254 anti-disease immunity. These independent age effects may reflect maturation of the 255 immune system as well as other physiological changes that decrease the propensity to 256 fever (13,19). Furthermore, our findings are consistent with independent effects of 257 transmission intensity on the acquisition of these two types of immunity. While the 258 results obtained for moderate and high transmission settings (aEIR >5) are consistent and 259 expected, and suggest that immunity develops faster in settings where individuals get 260 infected by P. falciparum more often, the results obtained for the lowest transmission 261 settings are harder to reconcile. These results were largely driven by observations 262 collected in the Walukuba site, and as such it is possible that site-specific characteristics 263 may have driven them. Walukuba was previously a relatively high transmission rural 264 area, but substantial decreases in transmission intensity have been observed since 2011, 265 likely due to urbanization. While our sensitivity analyses suggested that differences in the 266 prevalence of three well characterized host-genetic polymorphisms between sites do not 267 explain these discrepant results, it is still possible that other unmeasured site-specific 268 characteristics may have driven them. A lower parasite diversity in Walukuba, for 269 example, could cause this difference, as developing an effective immune response against 270 fewer parasite strains may be much easier than developing immunity against a more 271 diverse pool (20,21). Testing this hypothesis would require careful characterization of the 272 complexity and diversity of infections in each of our cohort settings. 273 274 While site specific characteristics may underlie the observed high levels of clinical 275 immunity against malaria in the low transmission setting, it is also possible that this 276 finding reflects biologically relevant differences in how immunity against malaria 277 develops. For example, it has been hypothesized that immunity may develop optimally in 278 individuals that are exposed at a low rate, and that more frequent infections may interfere 279 with the development of robust immune responses (22,23). Answering this question will 280 require further detailed studies across transmission settings, with careful characterization 281 of both exposure and infection outcomes. 282
There are several limitations to this study. With a study design including routine visits 283 every 3 months, we are likely to have missed several asymptomatic infections, 284 particularly in the moderate and high transmission settings. Moreover, since infections 285 were detected using microscopy, we were unable to detect sub-patent infections, and we 286 lack knowledge about the genetic complexity of each infection. While it is possible that 287 the expected values modeled here (expected parasite density and fever threshold) were 288 biased by these sources of measurement error, sensitivity analyses suggest that the 289 relationships observed were robust. Secondly, while we found an independent association 290 between the average household aEIR and both anti-parasite and anti-disease immunity, it 291 is not clear that this is the most relevant metric of exposure for the development of 292 clinical immunity to malaria. Alternative metrics such as the number of discrete 293 infections, the number of "strains" seen or the total parasite-positive time might be more 294 relevant, but require the collection of additional data, including more frequent sampling. 295
Finally, while this study provides very detailed insight into how two types of clinical 296 immunity to malaria develop in endemic settings as a function of age and repeated 297 exposure, it says nothing about the duration of immunity. 298
299
Prior studies have tried to model the processes driving acquisition of clinical immunity 300 against malaria. However, these models have been generally informed by aggregated 301 epidemiological data (age-incidence and age-prevalence) which limits their capacity to 302 isolate the contributions of age and repeated exposure (24-26). Our results quantify how 303 anti-parasite and anti-disease immunity develop in children across the malaria 304 transmission spectrum, and they support strong a strong independent effect of age and a 305 perhaps paradoxical effect of exposure. The methods proposed here to model anti-306 parasite and anti-disease immunity may also provide a framework to select individuals 307 with immune and non-immune phenotypes for evaluations of immune correlates of 308 protection. 309 We used data from three parallel cohort studies conducted in Uganda in sub-counties 322 chosen to represent varied malaria transmission(14). Walukuba, in Jinja district, is a peri-323 urban area near Lake Victoria that has the lowest transmission among the three (annual 324 entomological inoculation rate (aEIR) estimated to be 2.8(14)). Kihihi, in Kanungu 325 district, is a rural area in southwestern Uganda characterized by moderate transmission 326 (aEIR=32). Nagongera, Tororo district, is a rural area in southeastern Uganda with the 327 highest transmission (aEIR=310)(14,15). Details on how the study households and 328 participants were selected has been described elsewhere (14) . Briefly, all households were 329 enumerated, and then approximately 100 households were selected at random from each 330 site. Between August and September 2011, all children from these households aged 331 between 6 months and 10 years who met eligibility criteria were invited to participate. As 332 the cohorts were dynamic, additional children from participating households were invited 333 to participate if they became eligible while the study was ongoing. Unless participants 334
were withdrawn from the study either voluntarily or because they failed to comply with 335 study visits, they were followed-up until they reached 11 years of age. Children from 31 336 randomly selected additional households were enrolled between August and October 337 2013 to replace households in which all study participants had been withdrawn. For this 338 analysis, we used data collected from visits between August 2011 and November 2014. 339
The studies included passive and active follow-up of participants. Parents/guardians were 340 encouraged to bring their children to designated study clinics for any illness. All medical 341 care was provided free of charge, and participants were reimbursed for transportation 342 costs. All children who reported fever in the previous 24 hours or were febrile at the time 
Statistical analyses 373
The purpose of these analyses was to model and quantify the development of immunity 374 against symptomatic malaria, as a function of age and exposure, measured by the 375 household EIR. 376
We modeled two specific types of immunity that have been previously described as 377 components of immunity to malaria. We defined anti-parasite immunity as the ability to 378 control parasite densities upon infection and anti-disease immunity as the ability to 379 tolerate parasite infections without developing objective fever. Thus, for models of anti-380 parasite immunity, the outcome of interest was the parasite density recorded (using thick 381 blood smear) at each parasite positive study visit. For models of anti-disease immunity 382 the outcome of interest was the objective temperature recorded during parasite positive 383 visits, conditional on the parasite density. In addition, we also modeled overall immunity 384 against symptomatic malaria. For these analyses, the outcome of interest was the 385 probability of presenting with fever given infection (parasite positivity). 386
387
In order to model the association between the outcomes and covariates of interest we 388 used generalized additive models (gams). Gams provide a good framework, as they allow 389 for smooth non-linear relationships. Details on the specific models explored are provided 390 in the supplementary material. In summary, the models followed the following form. Where i is an index for individuals, j for households and k for specific visits. Thus, 404 345 represents the age of child i from household j during visit k, and 4 represents 405 the average annual EIR recorded for household j. We included the EIR as an average 406 (time-invariant) covariate, as we were interested in modeling the impact of the average 407 exposure to malaria over time on the development of clinical immunity. 408
All models were fitted in the R statistical framework using package mgcv(16). To 409 account for clustering, all models included random effects at the individual and 410 household levels. Best fitting models were selected based on Akaike's Informaiton 411
Criterion and the percent deviance explained. 412
413
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